BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 17362784)

  • 21. Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates.
    Qi S; Zhu S; Xu D; Wang X; Ouyang J; Jiang W; Vu MD; Bilolo K; Ma A; Johnson S; Daloze P; Bekersky I; Fitzsimmons WE; Chen H
    Transplantation; 2003 Apr; 75(8):1124-8. PubMed ID: 12717189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged survival with FK778 (malononitrilamide) monotherapy after small bowel transplantation: a large animal study.
    Zonta S; Alessiani M; ViganĂ² J; Doni M; Bardone M; Dominioni T; De Martino M; Scaglione M; Vicini E; Filisetti C; Biroli A; Bottazzi A; Villa C; Morbini P; Dionigi P
    Transplant Proc; 2007; 39(6):2021-3. PubMed ID: 17692681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation model.
    Deuse T; Schrepfer S; Reichenspurner H
    Transplantation; 2003 Dec; 76(11):1627-9. PubMed ID: 14702537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of malononitrilamide FK778 in a preclinical model of small bowel transplantation.
    Alessiani M; Zonta S; Abbiati F; Cobianchi L; Bardone M; Zitelli E; Doni M; ViganĂ² J; Mazzilli M; Lovisetto F; Dominioni T; Dionigi B; Lusona B; Morbini P; Molinaro MD; Dionigi P
    Transplant Proc; 2005; 37(6):2719-21. PubMed ID: 16182793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Oct; 38(8):2719-21. PubMed ID: 17098049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs.
    Kyles AE; Gregory CR; Griffey SM; Bernsteen L; Pierce J; Lilja HS; Morris RE
    Transplantation; 2003 Apr; 75(8):1128-33. PubMed ID: 12717190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survival.
    Fang YH; Joo DJ; Lim BJ; Huh KH; Kim MS; Suh H; Kim YS
    J Surg Res; 2011 Nov; 171(1):e133-7. PubMed ID: 21816421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FK778 and FK506 combination therapy to control acute rejection after rat liver allotransplantation.
    Yamamoto S; Okuda T; Yamasaki K; Tanaka H; Kubo S; Takemura S; Ikeda K; Minamiyama Y; Hirohashi K; Suehiro S
    Transplantation; 2004 Dec; 78(11):1618-25. PubMed ID: 15591950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
    [No Abstract]   [Full Text] [Related]  

  • 30. FK778: new cellular and molecular mechanisms of action.
    Schrepfer S; Deuse T; Koch-Nolte F; Detter C; Reichenspurner H
    Transplant Proc; 2006 Apr; 38(3):757-61. PubMed ID: 16647464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat.
    Ekberg H; Qi Z; Pahlman C; Veress B; Bundick RV; Craggs RI; Holness E; Edwards S; Murray CM; Ferguson D; Kerry PJ; Wilson E; Donald DK
    Transplantation; 2007 Nov; 84(9):1191-9. PubMed ID: 17998876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
    Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
    Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
    Pan F; Fisniku O; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H
    Transplant Proc; 2005; 37(1):134-6. PubMed ID: 15808572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival.
    Kanatani T; Lanzetta M; Owen E; Matsumoto T; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
    Transplant Proc; 2005 Jun; 37(5):2382-4. PubMed ID: 15964421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats.
    Zeng H; Waldman WJ; Yin DP; Knight DA; Shen J; Ma L; Meister GT; Chong AS; Williams JW
    Transplantation; 2005 Jan; 79(1):17-22. PubMed ID: 15714164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leflunomide controls rejection in hamster to rat cardiac xenografts.
    Xiao F; Chong AS; Foster P; Sankary H; McChesney L; Koukoulis G; Yang J; Frieders D; Williams JW
    Transplantation; 1994 Oct; 58(7):828-34. PubMed ID: 7940718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
    Williams JW; Xiao F; Foster P; Clardy C; McChesney L; Sankary H; Chong AS
    Transplantation; 1994 Apr; 57(8):1223-31. PubMed ID: 8178350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction with T-cell receptor antibody leads to long-term laryngeal allograft function.
    Knott PD; Dan O; Strome M
    Am J Otolaryngol; 2008; 29(6):398-402. PubMed ID: 19144301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of acute rejection after skin or cardiac transplantation by administration of donor antigens in the rat.
    Shirouzu Y; Hikida S; Tanigawa H; Shirouzu K
    Surg Today; 2004; 34(4):341-8. PubMed ID: 15052450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.